Skip to content

Clinical trials

Phase 2 Supranuclear Palsy, Progressive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Supranuclear Palsy, Progressive Phase: Phase 2 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20081
20161
20171
20181
20191
20201
20214
20232
20242
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4
Terminated3
Enrolling by invitation2
Recruiting2
Withdrawn1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adam Boxer3
AbbVie2
GemVax & Kael2
AlzProtect SAS1
Biogen1
Biojiva LLC1
EmeraMed1
Ferrer Internacional S.A.1
German Parkinson Study Group (GPS)1
Groupe Hospitalier Pitie-Salpetriere1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Supranuclear Palsy, Progressive22
Corticobasal Degeneration3
Multiple System Atrophy3
Tauopathies3
Frontotemporal Dementia2
Dementia1
Disease Progression1
Fatigue1
Frontotemporal Lobar Degeneration1
Neurodegenerative Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.